Lyell Immunopharma shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.5M | 1.3M | 1.94 |
| 2023-09-30 | $1.8M | 1.3M | 1.47 |
| 2023-06-30 | $3.7M | 1.2M | 3.18 |
| 2023-03-31 | $2.7M | 1.1M | 2.36 |
| 2022-12-31 | $3.9M | 1.1M | 3.47 |
| 2022-09-30 | $8.2M | 1.1M | 7.33 |
| 2022-06-30 | $3.2M | 489k | 6.52 |
| 2022-03-31 | $2.3M | 453k | 5.05 |
| 2021-12-31 | $1.3M | 171k | 7.75 |
| 2021-09-30 | $2.5M | 166k | 14.80 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management